References
- Bisse E, Wieland H. High performance liquid chromatographic separation of human haemoglobins—simultaneous quantitation of foetal and glycated haemoglobins. J Chromatogr 1988; 434(1)95–110
- Kutlar F, Kutlar A, Huisman T HJ. Separation of normal and abnormal hemoglobin chains by reversed phase high performance liquid chromatography. J Chromatogr 1989; 357(1)147–153
- Liu Y T, Old J M, Miles K, Fisher C A, Weatherall D J, Clegg J B. Rapid detection of α‐thalassaemia deletions and α‐globin gene triplication by multiplex polymerase chain reactions. Br J Hematol 2000; 108(2)295–299
- Harteveld K L, Heister A J, Giordano P C, Losekoot M, Bernini L. Rapid detection of point mutations and polymorphisms of the α‐globin genes by DGGE and SSCA. Hum Mutat 1996; 7(2)114–122
- Troxler H, Neuheiser F, Kleinert P, Kuster T, Heizmann C W, Sack R, Hunziker P, Neuhaus T J, Schmid M, Frischknecht H. Detection of a novel variant human hemoglobin by electrospray ionization mass spectrometry. Biochem Biophys Res Commun 2002; 292(4)1044–1047
- Frick P G, Hitzig W H, Betke K. A new hemoglobin anomaly associated with acute hemolytic episodes with inclusion bodies after sulfonamide therapy. Blood 1962; 20(9)261–271
- Altay C, Say B, Yetgin S, Huisman T HJ. α‐Thalassemia and β‐thalassemia in a Turkish family. Am J Hematol 1977; 2(1)1–15
- Curuk M A, Dimovski A J, Baysal E, Gu L H, Kutlar F, Molchanova T P, Webber B B, Altay C, Gurgey A, Huisman T HJ. Hb Adana or α259(E8)Gly→Aspβ2, a severely unstable α1‐globin variant, observed in combination with the − (α)20.5 kb α‐thalassemia‐1 deletion in two Turkish patients. Am J Hematol 1993; 44(4)270–275
- Nakatsuji T, Miwa S, Ohba Y, Miyaji T, Matsumoto N, Matsuoka I. Hemoglobin Tottori (α59[E8]Gly→Val). Hemoglobin 1981; 5(5)427–439
- Chan V, Chan V W, Tang M, Lau K, Todd D, Chan T K. Molecular defects in Hb H hydrops foetalis. Br J Haematol 1997; 96(2)224–228
- Liu T C, Chiou S S, Lin S F, Chen T P, Tseng W P, Chen P H, Chang J G. Molecular basis and hematological characterization of Hb H disease in Southeast Asia. Am J Hematol 1994; 45(4)293–297
- Waye J S, Eng B, Patterson M, Walker L, Carcao M D, Olivieri N F, Chui D H. Hemoglobin H (Hb H) disease in Canada: molecular diagnosis and review of 116 cases. Am J Hematol 2001; 68(1)11–15
- Traeger‐Synodinos J, Papassotiriou I, Metaxotou‐Mavrommati A, Vrettou C, Stamoulakatou A, Kanavakis E. Distinct phenotypic expression associated with a new hyperunstable α globin variant (Hb Heraklion, α1cd37(C2)Pro→0): comparison to other α‐thalassemic hemoglobinopathies. Blood Cells Mol Dis 2000; 26(4)276–284
- Stamoulakatou A, Athanasiou‐Metaxa M, Traeger‐Synodinos J, Lazaropoulou C, Harteveld K, Premetis E, Tsantali H, Zorai A, Giordano P, Papassotiriou I, Kanavakis E. Rare thalassemic syndrome caused by interaction of Hb Questembert (α1 codon 131, TCT→CCT, Ser→Pro) with an α‐thalassemia‐2 deletion: implications for diagnosis and management. Blood Cells Mol Dis 2004; 32(1)118–123